All
Proteomic and Molecular Changes in Cutaneous Melanoma Metastasis
Using mass spectrometry, researchers examined novel changes to gather updated metastasis information.
Baricitinib Offers Hope for Pediatric Atopic Dermatitis Patients
Results of a new study indicate that baricitinib offers a potential therapeutic option with a favorable benefit-risk profile for pediatric patients with moderate-to-severe AD.
Etanercept Improves Psoriasis Progression
Inhibitor etanercept alleviated pathological changes and inflammation in induced psoriasis.
What's Trending in Skin Care: April 2023
Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of April.
New Class of Immunotherapy May Help Fight Aggressive Skin Cancer
The results of a new study reveal that the the antibody works by activating the immune response to fight cancer and slows melanoma growth in mice.
The Role of Exercise in Atopic Dermatitis, Spontaneous Urticaria
Physical activity and exercise may lead to improved mental health but exacerbate skin conditions.
FDA Gives the Green Light for Cheek Wrinkle Solution
Galderma announced the approval of a injectable poly-L-lactic acid to correct fine lines and wrinkles.
Moderate-to-Severe Stress Associated With Skin Aging Manifestations
Patients more commonly reported skin aging manifestations when they experienced higher levels of stress.
Pointers With Portela: Why Does Vitamin C Serum Smell?
In this week’s Pointers with Portela, the 208SkinDoc explains why vitamin C serums can occasionally have an unpleasant smell.
Discovering Dermatology Times: April 2023
Learn more about the in-depth topics covered in the April 2023 issue of Dermatology Times®.
Four Abstracts on Eblasakimab and Farudodstat to be Presented at 1st International Societies for Investigative Dermatology Meeting
ASLAN Pharmaceuticals will present 2 late-breaking abstracts and 2 additional abstracts.
Expert Advice for Dermatology Advanced Practice Providers Starting Their Career
Learning from mentors and developing a solid foundation in dermatology are just a few of the necessary steps to boost your career as a dermatology APP.
Patients With Pressure Ulcers Face Compromised Skin Parameters
Such factors may include transepidermal water loss and skin barrier function.
Skin Changes, Thickness May Aid in Early Acromelagy Detection
With dermoscopy and skin thickness assessments, researchers said it may be possible to detect cutaneous-involved acromelagy.
The Liability of an Electronic Health Record System
At least 1 legal case suggests that providers have a duty to minimize risks during the transition period to a new electronic health record system.
Increased Risk of Suicide Attempts in Alopecia Areata Patients
The risk remained significantly increased for both sexes as well ,whether or not the patient had depression, substance use disorder, or alcohol use disorder.
Tranexamic Acid Injections May Be Efficacious in Acne Vulgaris
Researchers said the treatment may improve post-acne erythema.
Delgocitinib Reduced Itch, Pain in Patients With Hand Eczema
When compared to a vehicle control cream, researchers said delgocitinib cream proved more efficacious.
The Mainstream Patient: April 24
This week's edition of the Mainstream Patient features stories about addictive behaviors stemming from skin care culture, the 21 best hyaluronic acid serums, and the struggles behind finding the right vitiligo treatment.
Looking for Tax Advantages? Consider These 2 Asset Classes
Although our tax code changes somewhat regularly, both real estate and cash value life insurance have shown superior tax treatment for decades.
Oncology Pharmacists Are Crucial in Skin Cancer Management
From explaining how medications work and should be taken to reviewing potential adverse effects and financial details, pharmacists are crucial resources for patients undergoing treatment for skin cancer.
The Weekly Roundup: April 17-21
ICYMI, this week we had stories about melanoma management with pembrolizumab, advances in rosacea therapy, new phase 2 data of VP-315 for BCC, and more.
Tralokinumab Found to be Efficacious in Adolescents With Moderate to Severe Atopic Dermatitis
Results of the phase 3 ECZTRA 6 trial found that the efficacy of the drug was maintained by more than 50% of patients at 52 weeks.
European Commission Approves Ruxolitinib Cream for Non-Segmental Vitiligo
Ruxolitinib is the first and only approved treatment for repigmentation in the European Union.
1 in 5 With Spontaneous Urticaria Has Celiac Disease Autoantigen Expression
Researchers said expression of the autoantigen was increased in patients.
The Impact of Swimming on Atopic Dermatitis Flares
Researchers pooled evidence supporting the way these 2 factors correlate.
Patient Preferences in Topical Psoriasis Treatment
A new study revealed that psoriasis patient adherence is influenced by certain characteristics of topical medications.
FDA Issues Second CRL for Alvotech’s Adalimumab Biosimilar
Approval has been pushed back to June 28, 2023.
Compound Glycyrrhizin Injections More Efficacious in Acne Than Clindamycin
Researchers said using the injections and mesotherapy in patients with acne more effectively treated their acne.
In Mouse Study, Topical Emollient Reduced Atopic Dermatitis-Like Lesions
Researchers said emollients markedly reduced lesions and other atopic dermatitis-related factors.